Cargando…

The Different Mechanisms of Cancer Drug Resistance: A Brief Review

Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoori, Behzad, Mohammadi, Ali, Davudian, Sadaf, Shirjang, Solmaz, Baradaran, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651054/
https://www.ncbi.nlm.nih.gov/pubmed/29071215
http://dx.doi.org/10.15171/apb.2017.041
_version_ 1783272819266682880
author Mansoori, Behzad
Mohammadi, Ali
Davudian, Sadaf
Shirjang, Solmaz
Baradaran, Behzad
author_facet Mansoori, Behzad
Mohammadi, Ali
Davudian, Sadaf
Shirjang, Solmaz
Baradaran, Behzad
author_sort Mansoori, Behzad
collection PubMed
description Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents is growing quickly, effective chemotherapy agent has not been discovered against the advanced stage of cancer (such as invasion and metastasis). The cancer cell resistance against the anticancer agents can be due to many factors such as the individual’s genetic differences, especially in tumoral somatic cells. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi-drug resistance, cell death inhibiting (apoptosis suppression), altering in the drug metabolism, epigenetic and drug targets, enhancing DNA repair and gene amplification. In this review, we outlined the mechanisms of cancer drug resistance and in following, the treatment failures by common chemotherapy agents in the different type of cancers.
format Online
Article
Text
id pubmed-5651054
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tabriz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-56510542017-10-25 The Different Mechanisms of Cancer Drug Resistance: A Brief Review Mansoori, Behzad Mohammadi, Ali Davudian, Sadaf Shirjang, Solmaz Baradaran, Behzad Adv Pharm Bull Review Article Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents is growing quickly, effective chemotherapy agent has not been discovered against the advanced stage of cancer (such as invasion and metastasis). The cancer cell resistance against the anticancer agents can be due to many factors such as the individual’s genetic differences, especially in tumoral somatic cells. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi-drug resistance, cell death inhibiting (apoptosis suppression), altering in the drug metabolism, epigenetic and drug targets, enhancing DNA repair and gene amplification. In this review, we outlined the mechanisms of cancer drug resistance and in following, the treatment failures by common chemotherapy agents in the different type of cancers. Tabriz University of Medical Sciences 2017-09 2017-09-25 /pmc/articles/PMC5651054/ /pubmed/29071215 http://dx.doi.org/10.15171/apb.2017.041 Text en ©2017 The Authors. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
spellingShingle Review Article
Mansoori, Behzad
Mohammadi, Ali
Davudian, Sadaf
Shirjang, Solmaz
Baradaran, Behzad
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title_full The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title_fullStr The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title_full_unstemmed The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title_short The Different Mechanisms of Cancer Drug Resistance: A Brief Review
title_sort different mechanisms of cancer drug resistance: a brief review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651054/
https://www.ncbi.nlm.nih.gov/pubmed/29071215
http://dx.doi.org/10.15171/apb.2017.041
work_keys_str_mv AT mansooribehzad thedifferentmechanismsofcancerdrugresistanceabriefreview
AT mohammadiali thedifferentmechanismsofcancerdrugresistanceabriefreview
AT davudiansadaf thedifferentmechanismsofcancerdrugresistanceabriefreview
AT shirjangsolmaz thedifferentmechanismsofcancerdrugresistanceabriefreview
AT baradaranbehzad thedifferentmechanismsofcancerdrugresistanceabriefreview
AT mansooribehzad differentmechanismsofcancerdrugresistanceabriefreview
AT mohammadiali differentmechanismsofcancerdrugresistanceabriefreview
AT davudiansadaf differentmechanismsofcancerdrugresistanceabriefreview
AT shirjangsolmaz differentmechanismsofcancerdrugresistanceabriefreview
AT baradaranbehzad differentmechanismsofcancerdrugresistanceabriefreview